Illumina Reagents and Consumables
Closed Pre-Solicitation Posted
- Solicitation number
- 75N92025R00033
- Agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- San Diego, California 92122, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Heart, Lung, and Blood Institute (NHLBI), acting on behalf of the National Human Genome Research Institute (NHGRI), is seeking to procure Illumina reagents and consumables for genomic research equipment. The pre-solicitation notice indicates an intent to award a contract modification directly to Illumina, Inc. without full and open competition, specifically covering reagents for 201 sequencing and genotyping systems including NovaSeq X Plus, NovaSeq 6000, NextSeq, and MiSeq models. Interested parties may submit a capability statement up to 10 pages by June 18, 2025, at 12:00 PM Eastern Time, with submissions to be sent via email to Ethan Mueller and Dorothy Maxwell. The procurement emphasizes the proprietary nature of Illumina's equipment, noting that alternative manufacturer reagents cannot be used without potentially voiding warranties or compromising research results. Respondents must have an active registration in the System for Award Management (SAM.gov) and meet qualifications under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing.
The contract is currently classified as an unrestricted acquisition with a small business size standard of 1,000 employees, potentially eligible for set-aside categories including HUBZone, Women-Owned Small Business, Service-Disabled Veteran-Owned Small Business, and 8(a) programs. The current contract (75N92020D00022) is being extended for an additional 6 months, running from September 3, 2020, through March 2, 2026. While specific award values are not explicitly stated, the procurement covers a comprehensive range of reagents and consumables for advanced genomic research equipment. The solicitation is considered a rated order under the Defense Priorities and Allocations System, indicating potential priority status. Illumina, Inc., located in San Diego, California, is the sole-source contractor for this procurement, with the contract focusing on their specialized scientific instrumentation and associated consumable materials.
Notice text
THIS IS A NOTICE OF INTENT SYNOPSIS TO AWARD A CONTRACT MODIFICATION WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND- NAME).
The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA) on behalf of the National Human Genome Research Institute (NHGRI), intends to negotiate and award a contract modification without providing for full and open competition to:
Illumina, Inc.
5200 Illumina Way
San Diego CA 92122
THIS IS A SYNOPSIS. THIS IS NOT A SOLICITATION.
The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA) on behalf of the National Human Genome Research Institute (NHGRI), intends to negotiate and award a contract modification without providing for full and open competition (including brand-name) to Illumina, Inc., for the requirement entitled “Illumina Reagents and Consumables.”
Please see the attached documents for additional details and due dates for responses.
Files
| File | Type | Posted |
|---|---|---|
| 75N92025R00033.pdf | ||
| REV Mod SAM NOI pre-sol-notice_illumina_final_6-3-25.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity